Abstract The sirtuin family comprises seven NAD + -dependent deacetylases which control the overall health of organisms through the regulation of pleiotropic metabolic pathways. Sirtuins are important modulators of adipose tissue metabolism and their expression is higher in lean than obese subjects. At present, the role of sirtuins in adiposederived stem cells has not been investigated yet. Therefore, in this study, we evaluated the expression of the complete panel of sirtuins in adipose-derived stem cells isolated from both subcutaneous and visceral fat of non-obese and obese subjects. We aimed at investigating the influence of obesity on sirtuins' levels, their role in obesity-associated inflammation, and the relationship with the peroxisome proliferator-activated receptor delta, which also plays functions in adipose tissue metabolism. The mRNA levels in the four types of adipose-derived stem cells were evaluated by quantitative polymerase chain reaction, in untreated cells and also after 8 h of hypoxia exposure. Correlations among sirtuins' expression and clinical and molecular parameters were also analyzed. We found that sirtuin1-6 exhibited significant higher mRNA expression in visceral adipose-derived stem cells compared to subcutaneous adipose-derived stem cells of non-obese subjects. Sirtuin1-6 levels were markedly reduced in visceral adipose-derived stem cells of obese patients. Sirtuins' expression in visceral adipose-derived stem cells correlated negatively with body mass index and C-reactive protein and positively with peroxisome proliferator-activated receptor delta. Finally, only in the visceral adipose-derived stem cells of obese patients hypoxia-induced mRNA expression of all of the sirtuins. Our results highlight that sirtuins' levels in adipose-derived stem cells are consistent with protective effects against visceral obesity and inflammation, and suggest a transcriptional mechanism through which acute hypoxia up-regulates sirtuins in the visceral adiposederived stem cells of obese patients.
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Introduction
Sirtuins (SIRTs) are NAD + -dependent class III histone deacetylases [1] , which play important roles in modulating metabolic processes, are central to the control of energy homeostasis and deeply involved in adipose tissue (AT) metabolism [2] . SIRT1 is an important modulator of AT differentiation and remodeling. Indeed, SIRT1 inhibits adipogenesis and promotes fat mobilization by repressing activity of the peroxisome proliferator-activated receptor (PPAR) γ [3] , induces browning of white AT promoting energy expenditure over energy storage [4] , activates lipolysis [5] , improves insulin signaling [6] , and increases the expression of adiponectin [7] , which is inversely correlated with adiposity. Accordingly, the mRNA levels of SIRT1 are suppressed in AT of obese compared to normal-weight subjects [8, 9] . Although SIRT1 is the best known member of the family, the knowledge of the functions of the other less-described isoforms in AT is rapidly improving. SIRT2 has been shown to promote lipolysis and suppress adipocyte differentiation and adipogenesis through the inhibition of PPARγ [10, 11] ; SIRT3 controls thermogenesis in brown AT, and its reduction correlates with obesity [12] ; SIRT4 coordinates the balance between lipid synthesis and catabolism [13] ; finally, SIRT6 has been shown to inhibit triglyceride biosynthesis [14] .
Functions of peroxisome proliferator-activated receptor delta (PPARδ) in AT metabolism and weight control have also been uncovered. Indeed, PPARδ enhances fatty acid oxidation and energy uncoupling in AT, protects against dietinduced obesity and improves insulin sensitivity [15, 16] .
The obese AT dysfunction is in part due to its hypoxic microenvironment and low-grade chronic inflammation [17] . SIRT1 appears to be protective from obesity-induced inflammation, as its reduction causes macrophage recruitment and AT inflammation during chronic high-fat feeding. Consistently, SIRT1 expression negatively correlates with AT macrophage content in lean and obese subjects [18] . Moreover, SIRT1 can repress inflammatory gene expression in both adipocytes and macrophages [6, 19] . Collectively, the above mentioned data suggest a decisive role of SIRTs against metabolic derangements and inflammation in obesity.
Recently, we analyzed the features of the adiposederived stem cells (ASC), multipotent mesenchymal cells isolated from the stromal vascular fraction of the AT [20] , and their contribution to obesity-associated inflammation [21, 22] . To date, there are no data on the role of SIRTs in ASC. Therefore, in this study we evaluated the expression of the seven mammalian SIRTs in both subcutaneous and visceral ASC from non-obese and obese subjects and highlighted their modulation in obesity. Moreover, the role of SIRTs in obesity-related inflammation as well as the interplay with PPARδ were shown.
Materials and methods
Patients' enrollment and ASC isolation and culture ASC were obtained from both subcutaneous and visceral AT (SAT and VAT, respectively) of 12 individuals, 4 non-obese (2 males and 2 females, body mass index (BMI) < 30 kg/m 2 ) and 8 obese (2 males and 6 females, BMI > 30 kg/m 2 ). BMI, fasting plasma glucose (FPG), fasting insulin, glycated hemoglobin (HbA1c), total cholesterol, high density lipoprotein (HDL)-cholesterol, triglycerides, fibrinogen and C-reactive protein (CRP) were recorded. SAT and VAT specimens were obtained as previously described [22] . Tissues were digested and the collected cells plated in complete Dulbecco's modified Eagle's medium [21] . In the experiments described below, ASC were usually used at the 5 th passage of in vitro culture. The study was approved by the Institutional Review Board of the Policlinico Umberto I in Rome, and was compliant with Helsinki Declaration. The patients gave their informed consent before the surgical procedure.
Cell culture in hypoxic conditions
To evaluate cell behavior during oxygen deprivation, the culture plates were incubated for 8 h in a hypoxia chamber (Billups-Rothenberg, Del Mar, CA) flushed with an atmosphere containing 1 % oxygen, 5 % CO 2 and balanced with nitrogen, as previously described in detail [22] .
Quantitative PCR analysis
The mRNA expression level in the four types of ASC, cultured both in normoxic conditions and after exposure to hypoxia, was evaluated using TaqMan Array Microfluidic Cards designed with a purposely chosen panel of genes through the ABI Prism 7900HT Fast Real-Time PCR System Detector (Applied Biosystems, Foster City, CA) according to the manufacturer's default cycling conditions. The primer/ probe sets used were as follows: SIRT1, Hs01009005_m1; SIRT2, Hs00247263_m1; SIRT3, Hs00202030_m1; SIRT4, Hs00202033_m1; SIRT5, Hs00202043_m1; SIRT6, Hs0021 3036_m1; SIRT7, Hs00213029_m1; 18S, Hs99999901_s1. Relative quantitation of the SIRTs' gene expression was performed using the 2 −ΔΔCt method, using the average of the four samples of subcutaneous ASC from non-obese subjects in basal conditions as calibrator. Human 18S ribosomal RNA was used as endogenous reference gene.
Statistical analysis
Data were analyzed by GraphPad Prism v5.01 (GraphPad Software, San Diego, CA) and are presented as means ± SEM. The paired t-test was used to evaluate the effect of hypoxic treatment with respect to untreated cells and to analyze the differences of clinical parameters in the two groups of individuals. One-way ANOVA with Bonferroni post-test for multiple comparisons was used to compare the ASC populations. Spearman correlation coefficient test was used to analyze the relationships between variables. P values < 0.05 were considered significant.
Results

Clinical and anthropometric characteristics of the subjects
The characteristics of the patients are shown in Table 1 .
There was a significant difference in BMI between the two groups. Non-obese donors showed normal levels of the blood parameters evaluated. Differently, the obese patients had a mild alteration of glucose metabolism, but no diabetic subjects were involved in the study, as evidenced from the plasma levels of HbA1c. A mild dyslipidemia was also observed in obese, together with a significant increase of CRP blood values, compared to non-obese individuals.
Visceral ASC of non-obese subjects express high basal mRNA levels of SIRT1-6
We analyzed the basal expression of the seven SIRTs in both subcutaneous and visceral ASC isolated from nonobese and obese subjects. The evaluation and comparison of the ASC subpopulations from non-obese donors (nS-ASC vs. nV-ASC) showed that visceral ASC expressed significantly higher levels of SIRT1-6 compared to subcutaneous ASC (Fig. 1a) . Differently, the ASC isolated from obese patients (obS-ASC vs. obV-ASC) did not reveal any significant differences in SIRTs' expression, although the visceral adipose-derived stem cells of obese patients (obV-ASC) showed a trend to lower expression of SIRT1-6 (Fig. 1b) . SIRT7 had comparable basal expression in ASC of the two different AT sites, both in non-obese and obese subjects.
SIRT1-6 expression levels are markedly reduced in the obV-ASC
The above findings clearly indicate that obesity influences the expression of SIRTs in ASC. Further analysis of the data, performed to compare the SIRTs' expression in obese vs. non-obese subjects, highlighted indeed that the levels of SIRT1-6 were substantially lower in the obV-ASC than in the nV-ASC (Fig. 1d) . Differently, the nS and obS-ASC had comparable levels of SIRT1-6, although the obS-ASC presented a non-significant trend to higher expression (Fig. 1c) . Irrespective of the metabolic status of the donor, SIRT7 showed similar expression in both types of ASC.
SIRTs' mRNA expression correlates negatively with BMI and CRP and positively with PPARδ in visceral ASC Possible correlations among the mRNA expression of the seven SIRTs and clinical parameters listed in Table 1 were evaluated on the whole cohort of individuals. The analysis unveiled significant inverse correlations between SIRT1-6 mRNA expression and BMI or CRP in visceral ASC (Table 2) , whereas no association was evident in subcutaneous ASC (data not shown). As reported in our previous paper [22] , the basal mRNA levels of PPARδ and PPARγ were analyzed in the same four ASC subpopulations in which SIRTs' expression was evaluated, showing that the level of PPARδ was substantially lower in the obV-ASC than in the nV-ASC. Table 3 shows significant positive correlations among the mRNA expression of SIRT1-6 and PPARδ in visceral ASC, whereas no correlation was found among SIRTs and PPARγ.
Hypoxia induces the SIRTs' mRNA expression only in the obV-ASC As previously shown [22] , we evaluated the possible contribution of the four ASC subpopulations to obesityassociated inflammation, showing that the mRNA levels of the inflammation-related genes NF-kB and NF-kB transcriptional targets were up-regulated in the obV-ASC upon 8 h of hypoxia exposure. In the present study, we tested whether SIRTs could also represent a possible target for hypoxic adaptation in ASC. Figure 2a shows that 8 h of oxygen deprivation did not induce significant changes of the SIRTs' expression in the two types of subcutaneous ASC compared to the basal value (indicated by a horizontal line in the graph). On the contrary, the subpopulations of visceral ASC displayed a significant modulation of several SIRT genes (Fig. 2b) . In particular, all of the SIRTs were up-regulated in the obV-ASC, whereas SIRT5 and 6 were down-regulated and no significant change was observed for SIRT1, 2, 3, 4 and 7 in the nV-ASC. However, after 8 h of oxygen deprivation, the levels of SIRT1-6 in the obV-ASC were significantly lower compared to those observed in the nV-ASC (Fig. 3) .
Discussion
At present, there is no information regarding the expression of the complete panel of SIRTs in the ASC of the human fat depots. To address this issue, we investigated the mRNA expression levels of SIRTs in ASC isolated from SAT and VAT of non-obese and obese subjects. Our data showed very high levels of SIRT1-6 in the nV-ASC compared to the nS-ASC which could be related to the different metabolic activities of the two fat depots. It is consistent that the SIRTs' expression is higher in the nV-ASC, as they control pleiotropic metabolic pathways that increase the overall health of organisms [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Indeed, while SAT is deputed to store the excess of energy intake, such as free fatty acids (FFA) and glycerol that are deposited in the form of triglycerides, VAT has a larger effect on metabolism. VAT has a greater number of large adipocytes, which are more sensitive to lipolysis and insulin-resistant, thus contributing to the plasma FFA levels and glucose uptake. Moreover, it is more infiltrated with inflammatory cells and more capable of generating inflammatory markers, whereas has less preadipocyte differentiation capacity than SAT. Consequently, VAT accumulation is Values are expressed as the mean ± SEM *P < 0.05 and **P < 0.01 of BMI or CRP relative to the mRNA levels of each SIRT Values are expressed as the mean ± SEM.
*P < 0.05 and **P < 0.01 of the mRNA levels of PPARδ relative to those of each SIRT Fig. 2 Low oxygen determines up-regulation of the mRNA expression of SIRT1-7 compared to the basal levels in the obV-ASC. Q-PCR showing the changes in the mRNA levels of SIRTs in a the nS-and obS-ASC and b the nV-and obV-ASC after 8 h of oxygen deprivation. The amount of each SIRT gene, normalized to the endogenous control 18S and relative to the average of the four nS-ASC samples in basal conditions chosen as calibrator, was determined by the 2 −ΔΔCt method. All the values are expressed as the mean ± SEM. *P < 0.05 and **P < 0.01 of the effect of hypoxia relative to each untreated control, to which a value equal to 1 was arbitrarily assigned (horizontal lines in the graphs). associated with increased risk for diabetes, cardiovascular disease, hypertension and stroke [23] .
The SIRTs' activity is regulated by their ability to act as energy sensors [1] . In fact, a low-energy status that increases cellular levels of NAD + , such as fasting or calorie restriction, can activate SIRTs, whereas a high-energy status that decreases NAD + levels, including high-fat diet, reduces SIRT activity [24] . Consistently, several reports showed that SIRT1 expression is higher in lean compared to obese subjects [8, 9] and that transgenic mice overexpressing SIRT1 or mice treated with SIRT1 activators were protected against diet-induced obesity [25] [26] [27] . Conversely, AT-deletion of SIRT1 in mice fed with low-fat diet induced similar changes in gene expression than high-fat diet in wt mice, which showed reduced levels of SIRT1 mRNA and protein [28] . SIRT1 was reduced also in VAT and plasma of obese subjects with severe liver steatosis [29, 30] , and negatively correlated with visceral fat areas [31] . Other studies showed that under calorie restriction SIRT1, 2 and 3 levels in AT increased, as well as SIRT1 in plasma [12, [32] [33] [34] , whereas decrease of SIRT2 in VAT and SIRT4 in plasma was observed in obese [35, 36] . In agreement with all these findings, our results showed a strong reduction of the SIRTs' expression in the obV-ASC compared to the nV-ASC. Moreover, the observation that only in visceral ASC the mRNA levels of SIRT1-6 inversely correlated with BMI suggests a close link among SIRTs' expression and body fat amount and distribution. Accordingly, the inverse correlation between the plasma CRP levels of all of the individuals analyzed and the SIRTs' expression in the respective visceral ASC suggests that the protective effects of SIRTs concern also the obesity-associated inflammation, which is a peculiar feature of visceral obesity. Several reports showed that SIRT1, 2 and 6 exert anti-inflammatory effects through the inhibition of NF-kB signaling mediated by their deacetylase activity [6, [37] [38] [39] [40] . In contrast, other studies described that SIRT1, 2 and 6 may be positive regulators of inflammatory processes [41] [42] [43] [44] . It was suggested that NF-kB up-regulates SIRT1 at transcriptional level through the binding to a consensus NF-kB binding site on the promoter of SIRT1, also under inflammatory conditions [45, 46] . Interestingly, in addition to SIRT1, also SIRT2, 4 and 7 have potential NF-kB binding sites on their promoters (based on SABiosciences' proprietary DECODE database). In a recent study, performed on the same four ASC subpopulations used here, we analyzed the effects of hypoxia on the NF-kB pathway, highlighting that the obV-ASC exhibited hyper-responsiveness to hypoxia, which induced strong NF-kB activation and NF-kB target genes' expression, maximal after 2 and 8 h of oxygen deprivation, respectively [22] . In the present work, we evaluated whether SIRT genes could play a role in the NF-kB-mediated increase in inflammatory response. Actually, the previously observed NF-kB activation is consistent with the cellspecific up-regulation of the mRNA levels of all of the SIRTs observed after 8 h of hypoxia exposure solely in the obV-ASC, that we report here. Therefore, overall, our results support a transcriptional action of NF-kB on the SIRT genes in the obV-ASC. In agreement with Zhang et al., who suggested that SIRT1 up-regulation by NF-kB could be a ubiquitous auto-protective response of the cells to inflammatory events [45] , we hypothesize that a similar regulatory mechanism may also exist in the obV-ASC. Indeed, the hypoxia-induced SIRTs' increase may result in a negative feedback loop controlling NF-kB signaling through the SIRTs' deacetylase activity to attenuate the deregulated inflammatory response of the obV-ASC. This notion is supported by the observation that the other three ASC subpopulations, that did not show NF-kB activation after 2 h of hypoxia exposure [22] , do not exhibit even the enhancement of the SIRTs' expression. However, it should be noted that despite acute hypoxia increases the SIRTs' expression in the obV-ASC, the levels remained significantly lower than those of the nV-ASC. Consistently, the findings that the obV-ASC also constitutively expressed significantly lower levels of SIRT genes when compared to the nV-ASC, clearly indicate that in the obV-ASC, which underwent chronic exposition to an altered and hypoxiaremodeled AT microenvironment, the above proposed auto-protective mechanism against inflammatory events is prevented. In AT, PPARγ plays known functions such as adipocyte differentiation and up-regulation of genes involved in lipogenesis and triglyceride storage [47] . Consistently, we observed an inverse trend between PPARγ and SIRTs' expression. However, several effects of PPARδ in AT, opposite to those of PPARγ, have been also elucidated. Interestingly, like SIRTs, PPARδ is able to protect against obesity [15, 16] . In agreement with these findings, our results showed the existence of a positive relationship between PPARδ and SIRTs in visceral ASC suggesting that the protective effects of SIRTs may involve PPARδ. Accordingly, it has been recently shown that PPARδ upregulates SIRT1 expression at the transcriptional level [48, 49] . These findings clearly show another possible regulator of SIRTs in AT.
Although, in our study, the assessment of SIRTs' expression was performed only at mRNA level, the results have high reproducibility and strong statistical significance.
In conclusion, this study for the first time analyzes the expression of the seven SIRTs in the ASC of both subcutaneous and visceral human fat depots of non-obese and obese subjects. The results highlight the influence of obesity on the SIRTs' expression, a possible mechanism through which SIRTs are involved in obesity-associated inflammation, as well as the interplay with PPARδ. Importantly, these findings also indicate interesting novel pathophysiological frameworks for SIRTs to explore in ASC.
